Claudine Bruck is Director of NAVIDEA BIOPHARMACEUTICALS, INC.. Currently has a direct ownership of 16,519 shares of NAVB, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2021, when has been sold 3,969 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.5K
0% 3M change
0% 12M change
Total Value Held $0

Claudine Bruck Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2021
BUY
Grant, award, or other acquisition
-
3,969 Added 19.37%
16,519 Common Stock
Jan 13 2021
BUY
Grant, award, or other acquisition
-
2,500 Added 16.61%
12,550 Common Stock

Also insider at

ANVS
Annovis Bio, Inc. Healthcare
CB

Claudine Bruck

Director
Dublin, OH

Track Institutional and Insider Activities on NAVB

Follow NAVIDEA BIOPHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NAVB shares.

Notify only if

Insider Trading

Get notified when an Navidea Biopharmaceuticals, Inc. insider buys or sells NAVB shares.

Notify only if

News

Receive news related to NAVIDEA BIOPHARMACEUTICALS, INC.

Track Activities on NAVB